Caption: Stock-Sector Interview with NovaBay CEO Highlights Prospects for the Company’s FDA-Cleared, Advanced Wound Cleanser, NeutroPhase®, and its Development Pipeline

Credit: NovaBay Pharmaceuticals, Inc.